It also noted strong continuous glucose monitor (CGM) attachment rates. Additionally, Medtronic Diabetes saw international revenue grow on increasing CGM attachment as users upgrade to the Simplera ...

VCG / Contributor / Getty Images Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management ...

Medtronic brought in revenues of $8.3bn for the quarter, up 2.5% from the same period in 2024. Image credit: Shutterstock / JHVEPhoto. Medtronic posted a strong profit for Q3 of fiscal year 2025, ...

(Reuters) - Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors and said the problems would persist in the ...

Medtronic (NYSE:MDT) traded lower in pre-market hours Tuesday, down 4.54% to $88.60 as of 08:20 AM ET, despite reaffirming its full-year guidance alongside its Q3 FY25 results. The MedTech giant ...

NSW must make the second-highest Sheffield Shield total this season if they are to beat Tasmania and reach the final Tons to Jimmy Peirson and Jack Wildermuth against top side South Australia have ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

Seventeen years before Medtronic’s recent FDA approval for the world’s first adaptive deep brain stimulation (DBS) system for Parkinson’s disease, Scott Stanslaski was just starting his work on the ...

Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release ...